Loading...
Loading...
Of the 2 tracked institutions holding GGR, 2 have a 3-year clone track record — 2 of them beat the S&P. Average holder's clone alpha: +6.5pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 2 tracked institutional investors we monitor, GGR (GOGORO INC) is held with a combined value of $206.56K across 51,833 shares. The largest holder is RENAISSANCE TECHNOLOGIES LLC with a position worth $112.13K. CITADEL ADVISORS LLC opened a new position in the most recent quarter. 1 fund reduced its position.
Total Institutional Value
$206.56K
Total Shares Held
51,833
Institutional Holders
2
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $112.13K | 0.00% | -1.1% |
| 2 | CITADEL ADVISORS LLC | $94.42K | 0.00% | New |
As of the latest SEC 13F filings, RENAISSANCE TECHNOLOGIES LLC is the largest institutional holder of GGR with a position worth $112.13K, representing 0.00% of their portfolio. In total, 2 institutional investors hold GGR with a combined value of $206.56K.
In the most recent quarter, 1 fund opened a new position in GGR. Additionally, 1 reduced their positions.
Institutional investors hold $206.56K worth of GGR stock across 2 positions. The largest institutional holder is RENAISSANCE TECHNOLOGIES LLC with $112.13K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GGR, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GGR positions.
Last Close
$3.00
2026-10-21
YTD
-1.0%
33% of 52-week range
